Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Egrifta (tesamorelin) has been approved for the treatment of HIV-associated lipodystrophy, according to a November 10 announcement from...
HIV-positive people are aging faster than those not infected HIV, possibly due to the body’s hyperactive response to the virus.
Montreal-based Theratechnologies announced yesterday that the U.S. Food and Drug Administration (FDA) will reschedule its meeting with...
If approved, tesamorelin will be sold in the United States by EMD Serono.
A new non-nuke, the apparent cure of an HIV-positive patient receiving a bone marrow transplant and the possibility of earlier...
The company also confirmed a proposed deal with EMD Serono to sell the drug in the United States once it is approved.
Treatment with a tesamorelin resulted in a significant loss of visceral adipose tissue (VAT)—deep belly fat—compared with a placebo
Opportunistic infection management is inching back into the research spotlight with HIV control.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.